Biosyntech (Biosyntech) Total Assets

: $5.02 Mil (As of Dec. 2009)

View and export this data going back to 2000. Start your Free Trial

Biosyntech's Total Assets for the quarter that ended in Dec. 2009 was $5.02 Mil.

Total Assets is connected with ROA %. Biosyntech's annualized ROA % for the quarter that ended in Dec. 2009 was -263.73%. Total Assets is also linked to Revenue through Asset Turnover. Biosyntech's Asset Turnover for the quarter that ended in Dec. 2009 was 0.00.

Biosyntech Total Assets Historical Data

The historical data trend for Biosyntech's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosyntech Annual Data

Trend

Mar00

Mar01

Mar02

Mar03

Mar04

Mar05

Mar06

Mar07

Mar08

Mar09

Total Assets

Get a 7-Day Free Trial

3.92

12.72

14.07

6.10

5.69

Biosyntech Quarterly Data
	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09
Total Assets	Get a 7-Day Free Trial															8.71	5.69	4.64	4.72	5.02

Biosyntech Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Biosyntech's Total Assets for the fiscal year that ended in Mar. 2009 is calculated as

Total Assets	=	Total Equity (A: Mar. 2009 )	+	Total Liabilities (A: Mar. 2009 )
	=	-5.265	+	10.959
	=	5.69

Biosyntech's Total Assets for the quarter that ended in Dec. 2009 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2009 )	+	Total Liabilities (Q: Dec. 2009 )
	=	-12.816	+	17.831
	=	5.02

Biosyntech (OTCPK:BSYI) Total Assets Explanation

Total Assets is connected with ROA %.

Biosyntech's annualized ROA % for the quarter that ended in Dec. 2009 is

ROA %	=	Net Income (Q: Dec. 2009 )	/	( (Total Assets (Q: Sep. 2009 )	+	Total Assets (Q: Dec. 2009 ))	/ count )
	=	-12.832	/	( (4.716	+	5.015)	/ 2 )
	=	-12.832	/	4.8655
	=	-263.73 %

Note: The Net Income data used here is four times the quarterly (Dec. 2009) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Biosyntech's Asset Turnover for the quarter that ended in Dec. 2009 is

	Asset Turnover
=	Revenue (Q: Dec. 2009 )	/	( (Total Assets (Q: Sep. 2009 )	+	Total Assets (Q: Dec. 2009 ))	/ count )
=	0.001	/	( (4.716	+	5.015)	/ 2 )
=	0.001	/	4.8655
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Biosyntech Total Assets Related Terms

Thank you for viewing the detailed overview of Biosyntech's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosyntech (Biosyntech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosyntech Inc (OTCPK:BSYI) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

475 Boulevard Armand-Frappier, Laval, QC, CAN, H7V 4B3

Website

http://www.biosyntech.com

Biosyntech Inc is engaged in developing advanced biotherapeutics thermogels specifically designed for tissue repair and delivery of therapeutic agents. The company's products include BST-CarGel, BST-InPod, BST-DermOn, BST-Ossifil and BST-Ossifix and BST-Disc for intervertebral disc restoration.

Biosyntech (Biosyntech) Headlines

No Headlines